Parexel Clinical Trial Regulatory Services consultants share what you should be doing now to prepare for the coming changes.
Read Flipbook
The science of ethnobridging – a way to implement cost-effective, multi-ethnic approaches to global clinical trial research and drug development.
Read Flipbook
In the face of supportive pharmaceutical industry policies, biosimilar drug development in China is riding on an upward trend.
Read Article
Meet our team of China drug development experts
Read Flipbook
Learn about the services and approaches that Parexel Biotech offers to help you make an exponential difference in patients’ lives.
Read Flipbook
See how we helped a client quickly deliver on the issuance of an FDA Warning Letter to achieve product endorsement.
Read Flipbook
Parexel's Regulatory Consulting Services can help you prepare for the EU CT Regulation
Read Flipbook
Amy McKee, Vice President Regulatory Consulting Services, addresses some of the most common misconceptions about working with the FDA.
Read Article
The COVID-19 pandemic has seriously impacted the US healthcare system and supportive manufacturing facilities. Some consumers and healthcare professionals are currently experiencing difficulties...
Read Article
The UK national health technology assessment (HTA) body, the National Institute for Health and Clinical Excellence (NICE), made a long-awaited announcement last week: NICE has expanded the...
Read Article
Our team is here to help you navigate today’s regulatory environment. Learn more...
Read Flipbook
Watch Video
We have some tips for mapping your strategy
Read Article
Read Flipbook
Learn about patient recruitment strategies in Asia that will reduce the clinical trial burden, as published in Pharma Focus Asia in January 2018.
Read Flipbook
Read Flipbook
It’s never too early to start crafting a global regulatory submissions strategy.
Read Flipbook
